| 18.20 Delayed Data As of Sep 20 |  +0.34 / +1.90%Today’s Change | 11.00 Today|||52-Week Range 22.82 | +41.86% Year-to-Date |
| Previous close | 17.86 |
| Today’s open | 17.85 |
| Day’s range | 17.76 - 18.52 |
| Volume | 1,603,837 |
| Average volume (3 months) | 806,185 |
| Market cap | $1.2B |
| Earnings growth (last year) | -16.19% |
| Earnings growth (this year) | -20.01% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +15.44% |
| P/E ratio | NM |
| Price/Sales | 152.11 |
| Price/Book | 7.24 |
| Today’s change | Today’s % change | |
|---|---|---|
| ALECAlector Inc | +1.42 | +7.68% |
| MNTAMomenta Pharmaceutic... | +0.06 | +0.45% |
| RDUSRadius Health Inc | -0.39 | -1.35% |
| RGNXRegenxbio Inc | +0.48 | +1.22% |
| Next reporting date | November 14, 2019 |
| EPS forecast (this quarter) | -$0.38 |
| Annual revenue (last year) | $4.7M |
| Annual profit (last year) | -$66.6M |
| Net profit margin | -1,405.02% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director J. Scott Wolchko |
Chief Scientific Officer Daniel D. Shoemaker |
Corporate headquarters San Diego, California |
